Repeated steroid pulse therapies in HCV-positive liver recipients: Significant risk factor for HCV-related graft loss

Transplantation Proceedings

Volumn 37, Issue 4, 2005, Pages 1700-1702

  Bahra, M ^a   Neumann, U P ^a   Jacob, D ^a   Langrehr, J M ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; METHYLPREDNISOLONE; MIDDLE AGED; MUROMONAB-CD3; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TACROLIMUS; TREATMENT OUTCOME;

EID: 20344401341     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.03.081     Document Type: Conference Paper

References (13)

1. C. Ferya, L. Caccamo, G.J. Alexander European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerned Action on Viral Hepatitis (EUROHEP) Group Gastroenterology 117 1999 619
2. E.J. Gane, B.C. Portmann, N.V. Naoumov Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815
3. M. Berenguer, M. Prieto, J. Cordoba Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation association with treatment of rejection J Hepatol 28 1998 756
4. Banff schema for grading liver allograft rejection an international consensus document Anonymous Hepatology 25 1997 658
5. E.J. Gane, N.V. Naoumov, K.P. Qian A longitudinal analysis of hepatitis C virus replication following liver transplantation Gastroenterology 110 1996 167
6. H.R. Rosen, C.R. Shackleton, L. Higa Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation Am J Gastroenterol 92 1997 1453
7. S. Brillanti, M. Vivarelli, N. De Ruvo Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation Liver Transpl 8 2002 884
8. N.M. Kneteman Steroid-free immunosuppression balancing efficacy and toxicity Liver Transpl 7 2001 698
9. A. Regev, E. Molina, R. Moura Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation Liver Transpl 10 2004 1233
10. H. Auchincloss Jr, D.H. Sachs W.E. Pau Fundamental immunology 1993 Raven Press New York 1099
11. K. Sugimoto, F. Ikeda, J. Stadanlick Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection Hepatology 38 2003 1437
12. J.R. Lake The role of immunosuppression in recurrence of hepatitis C Liver Transpl 9 2003 S63
13. M. Bahra, U.P. Neumann, M. Harren Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation impact on clinical course and histologic damage Transplant Proc 34 2002 2934